COMPARING WHITE LIGHT VERSUS BLUE LIGHT CYSTOSCOPY RECURRENCE OUTCOMES AMONG NON-MUSCLE INVASIVE BLADDER CANCER PATIENTS IN AN EQUAL ACCESS SETTING: A PROPENSITY SCORED MATCHED ANALYSIS

被引:0
|
作者
Sanjay, Das
William, Aronson
Ali, Nasrallah
Stephen, Williams B.
Trustram, Eve Claire
Lin, Gu
Joshua, Parrish
Amanda, De Hoedt M.
Chad, Mckee
Stephen, Freedland J.
机构
[1] UCLA Hlth, Los Angeles, CA USA
[2] Univ Texas Med Branch, Galveston, TX USA
[3] Durham VA Hlth Care Syst, Durham, NC USA
[4] Photocure Inc, Princeton, NJ USA
[5] Cedars Sinai Med Ctr, Los Angeles, CA USA
关键词
D O I
10.1016/j.urolonc.2024.01.200
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
163
引用
收藏
页码:S69 / S70
页数:2
相关论文
共 50 条
  • [31] Recurrence rates in high-risk non-muscle invasive bladder tumors - the real impact of HAL blue light fluorescence cystoscopy and TURB
    Geavlete, B.
    Jecu, M.
    Multescu, R.
    Georgescu, D. A.
    Geavlete, P.
    EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (08) : 697 - 697
  • [32] Long-Term Outcomes and Costs Among BCG-treated High-Risk Non-Muscle Invasive Bladder Cancer Patients in an Equal Access Setting
    Williams, S. B.
    Howard, L. E.
    Foster, M. L.
    Klaassen, Z.
    Li, H.
    Sieluk, J.
    Imai, K.
    Sbar, E., I
    De Hoedt, A. M.
    Freedland, S. J.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2020, 38 (12) : 902 - 902
  • [33] Long-term outcomes among BCG-treated high-risk non-muscle invasive bladder cancer patients in an equal access setting.
    Williams, Stephen B.
    Howard, Lauren
    Foster, Meagan
    Klaassen, Zachary William Abraham
    Sieluk, Jan
    Li, Haojie
    Imai, Kentaro
    Sbar, Eric
    De Hoedt, Amanda M.
    Freedland, Stephen J.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [34] Response to letter to the editor on the systematic review "Narrow band imaging versus white light cystoscopy alone for transurethral resection of non-muscle invasive bladder cancer"
    Dahm, Philipp
    Maisch, Philipp
    Lane, Giulia I.
    WORLD JOURNAL OF UROLOGY, 2024, 42 (01)
  • [35] Contemporary cost-consequence analysis of blue light cystoscopy with hexaminolevulinate in non-muscle-invasive bladder cancer
    Klaassen, Zachary
    Li, Kathy
    Kassouf, Wassim
    Black, Peter C.
    Dragomir, Alice
    Kulkarni, Girish S.
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2017, 11 (06): : 173 - 181
  • [36] Non-muscle Invasive Bladder Cancer: fluorescence-truncated versus White-light TUR-B
    Luemmen, Gerd
    AKTUELLE UROLOGIE, 2018, 49 (05) : 383 - +
  • [37] Comparing oncological outcomes and safety between photodynamic diagnosis-assisted and white-light transurethral resection in elderly patients with non-muscle invasive bladder cancer
    Matsushita, Yuto
    Tsuchiya, Yoshihiro
    Ishikawa, Gaku
    Sano, Asuka
    Takemura, Ayana
    Watanabe, Shunsuke
    Watanabe, Kyohei
    Watanabe, Hiromitsu
    Tamura, Keita
    Motoyama, Daisuke
    Otsuka, Atsushi
    Inamoto, Teruo
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2025,
  • [38] Prospective evaluation of blue-light flexible cystoscopy with hexaminolevulinate in non-muscle-invasive bladder cancer
    Lotan, Yair
    Chaplin, Iftach
    Ahmadi, Hamed
    Meng, Xiaosong
    Roberts, Sidney
    Ladi-Seyedian, Sanam
    Bagrodia, Aditya
    Margulis, Vitaly
    Woldu, Solomon
    Daneshmand, Siamak
    BJU INTERNATIONAL, 2021, 127 (01) : 108 - 113
  • [39] Second transurethral resection for high-risk non-muscle invasive bladder cancer patients: a propensity score matched analysis
    Matsushita, Yuto
    Watanabe, Kyohei
    Watanabe, Hiromitsu
    Tamura, Keita
    Motoyama, Daisuke
    Ito, Toshiki
    Sugiyama, Takayuki
    Otsuka, Atsushi
    Miyake, Hideaki
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2020, 50 (06) : 718 - 721
  • [40] ONE YEAR RECURRENCE RATES IN NON-MUSCLE INVASIVE BLADDER CANCER AFTER HAL CYTOSCOPY - BLUE LIGHT IMPACT IN THE LONG RUN
    Geavlete, B.
    Multescu, R.
    Georgescu, D.
    Jecu, M.
    Geavlete, P.
    JOURNAL OF ENDOUROLOGY, 2010, 24 : A125 - A125